We were covered in this month's newsletter of the Wageningen University. Read the full story on the WUR's website:

Our online tour through the Surfix facilities is -just like 2020- coming to an end. We’ll see you back in 2021 with some exciting updates and insights about our biochip. 

"Hi and welcome to Surfix!"... These words mark the intro of our new video series, where we step behind the technical curtain of microfluidics and photonic biochips. 

Together with our partners we have been featured in a Wevolver article on integrated photonics, sponsored by PhotonDelta. The article summarizes the photonic biosensor technology and their usage for cost-effective mass application of biosensors for bed-side testing.Read the whole article here.

A team of Compamed, the leading trade fair for medical technology, visited us at our facilities on the Wageningen University Campus. Our colleagues, Dr. Anke Schütz-Trilling and Hans Dijk, have presented our most recent project: The development of a biosensor based on the photonic biochip, which can be used as a fast, reliable and inexpensive mass test for covid-19. Check out the video (3min) here.

This week's issue of Bits&Chips offers a great article on Surfix's development of a SARS-CoV-2 test, based on photonic biochips and selective nano-coatings. The three Dutch companies Surfix, Lionix and Qurin are developing a biochip along with Photondelta in a public- private partnership to unloc the potential of integrated photonics for corona testing. Read the full article here.